- Home
- ERAS vs DNUT Comparison
ERAS vs DNUT Comparison
Compare ERAS & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- DNUT
- Stock Information
- Founded
- ERAS 2018
- DNUT 1937
- Country
- ERAS United States
- DNUT United States
- Employees
- ERAS N/A
- DNUT N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- DNUT Food Chains
- Sector
- ERAS Health Care
- DNUT Consumer Staples
- Exchange
- ERAS Nasdaq
- DNUT Nasdaq
- Market Cap
- ERAS 484.4M
- DNUT 505.6M
- IPO Year
- ERAS 2021
- DNUT 2021
- Fundamental
- Price
- ERAS $1.58
- DNUT $3.60
- Analyst Decision
- ERAS Strong Buy
- DNUT Buy
- Analyst Count
- ERAS 6
- DNUT 6
- Target Price
- ERAS $4.50
- DNUT $6.22
- AVG Volume (30 Days)
- ERAS 714.7K
- DNUT 4.4M
- Earning Date
- ERAS 08-12-2025
- DNUT 08-07-2025
- Dividend Yield
- ERAS N/A
- DNUT 2.92%
- EPS Growth
- ERAS N/A
- DNUT N/A
- EPS
- ERAS N/A
- DNUT N/A
- Revenue
- ERAS N/A
- DNUT $1,538,841,000.00
- Revenue This Year
- ERAS N/A
- DNUT N/A
- Revenue Next Year
- ERAS N/A
- DNUT $2.93
- P/E Ratio
- ERAS N/A
- DNUT N/A
- Revenue Growth
- ERAS N/A
- DNUT N/A
- 52 Week Low
- ERAS $1.01
- DNUT $2.50
- 52 Week High
- ERAS $3.31
- DNUT $12.68
- Technical
- Relative Strength Index (RSI)
- ERAS 53.64
- DNUT 52.72
- Support Level
- ERAS $1.44
- DNUT $3.37
- Resistance Level
- ERAS $1.64
- DNUT $3.87
- Average True Range (ATR)
- ERAS 0.10
- DNUT 0.19
- MACD
- ERAS 0.01
- DNUT 0.01
- Stochastic Oscillator
- ERAS 61.54
- DNUT 66.71
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.